ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,126Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 1187

$579K Total Retail Price of All Prescriptions

Rank: 137 out of 1187

410 Patients Receiving at Least One Drug in Part D
46%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 410 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

4% of this provider’s 410 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 5,614 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 469 305 1 5
SIMVASTATIN 448 297 2 1
LISINOPRIL 370 236 3 4
ZOLPIDEM TARTRATE 321 119 4 14
METFORMIN HCL 310 208 5 7
AMLODIPINE BESYLATE 241 161 6 2
SEROQUEL XR 232 23 7 214
IBUPROFEN 225 146 8 59
BUSPIRONE HCL 195 83 9 153
LEVOTHYROXINE SODIUM 190 123 10 3
HYDROCHLOROTHIAZIDE 189 161 11 9
GABAPENTIN 188 70 12 23
PROAIR HFA 179 104 13 41
NAPROXEN 156 92 14 72
METOPROLOL TARTRATE 153 96 15 10
SERTRALINE HCL 145 62 16 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 140 105 17 39
RANITIDINE HCL 134 69 18 69
VENLAFAXINE HCL ER 128 44 19 121
PAROXETINE HCL 121 63 20 81
FLUOXETINE HCL 116 30 21 108
LANTUS 109 60 22 77
NEXIUM 108 76 23 15
ADVAIR DISKUS 105 42 24 35
QUETIAPINE FUMARATE 103 22 25 75
GLIPIZIDE 99 57 26 71
DIOVAN 96 69 27 17
CLONIDINE HCL 94 47 28 73
RISPERIDONE 93 48 29 58
INSULIN SYRINGE 90 53 30 128
ATORVASTATIN CALCIUM 83 63 31 6
FUROSEMIDE 81 65 32 8
ENALAPRIL MALEATE 80 54 33 27
DIOVAN HCT 79 34 34 40
CARVEDILOL 77 57 35 19
ATENOLOL 76 52 36 18
FLOVENT HFA 76 48 36 216
AZITHROMYCIN 76 50 36 24
CYCLOBENZAPRINE HCL 72 12 R 39 87
GEMFIBROZIL 72 48 39 196
GLIMEPIRIDE 70 44 41 30
SYMBICORT 68 44 42 176
FLUTICASONE PROPIONATE 67 39 43 31
SINGULAIR 67 37 43 67
BENZTROPINE MESYLATE 63 13 R 45 133
DONEPEZIL HCL 61 48 46 26
ESCITALOPRAM OXALATE 60 0 47 51
AMITRIPTYLINE HCL 59 0 R 48 190
ZALEPLON 58 27 49 375
TAMSULOSIN HCL 58 40 49 29
PRAVASTATIN SODIUM 57 31 51 12
LOSARTAN POTASSIUM 57 40 51 21
BUPROPION HCL 56 15 53 380
GLIPIZIDE XL 53 35 54 117
CILOSTAZOL 53 36 54 242
VENTOLIN HFA 52 29 56 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.